[144] RESMED INC SEC Filing

Rhea-AI Filing Summary

ResMed (RMD) received a Form 144 notice for a proposed insider sale. The filing lists 8,011 common shares to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $2,000,773.19 and an approximate sale date of November 7, 2025.

The shares were acquired via an option originally granted on November 14, 2018, with acquisition and cash payment dated November 7, 2025. As context, the filing shows 145,966,294 shares outstanding. Recent activity disclosed in the notice includes three prior sales of 8,009 shares each on August 7, 2025, September 8, 2025, and October 7, 2025, with gross proceeds of $2,238,378.55, $2,227,590.42, and $2,265,332.03, respectively.

The notice indicates sales may occur using standard brokerage methods on a national exchange.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8011	2000773.19	145966294	11/07/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/07/2025	Option Granted - 11/14/2018	Issuer			8011	11/07/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	08/07/2025	8009	2238378.55
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	09/08/2025	8009	2227590.42
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	10/07/2025	8009	2265332.03

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ResMed (RMD)'s new Form 144 disclose?

A proposed sale of 8,011 common shares on the NYSE via Fidelity Brokerage Services LLC, with an approximate sale date of November 7, 2025 and an aggregate market value of $2,000,773.19.

What is the class and exchange for the RMD shares to be sold?

The filing lists Common shares to be sold on the NYSE.

How many ResMed (RMD) shares are outstanding, per the notice?

The filing shows 145,966,294 shares outstanding.

How were the shares in the RMD Form 144 acquired?

They were acquired via an option granted on November 14, 2018, with acquisition and cash payment dated November 7, 2025.

What recent RMD insider sales are disclosed in the notice?

Three sales of 8,009 shares each on Aug 7, 2025, Sep 8, 2025, and Oct 7, 2025 with gross proceeds of $2,238,378.55, $2,227,590.42, and $2,265,332.03.

Who is the broker listed in the RMD Form 144?

The broker is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.